02.25.26 -- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact

Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.

Meeting the growing need for oligonucleotides means having the right tools. Learn about the nine indispensable components, such as synthesis columns and C&D systems, for your facility.

Go beyond the ELISA by leveraging mass spectrometry. Identify specific high-risk proteins and ensure your purification process meets the highest standards of safety.

Explore how chromatography resins are evolving from purification tools to therapeutic agents in cancer treatment, with insights into their chemical properties and clinical potential.

Optimizing input parameters like DBC and resin durability is key to boosting productivity in downstream bioprocessing. Discover how to tailor resin choices to meet your specific process requirements.

Watch how advanced resin technology improves biopharmaceutical purification, as well as enhanced performance, extended resin life, and reduced manufacturing costs.

With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

Fill‑finish is evolving as biologics, and advanced therapies shift capacity and sterility needs. Automation, emerging tech, and data‑driven methods are boosting efficiency in aseptic production.